港股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
和誉-B
13.460
-0.090
-0.66%
手动刷新
成交量：
131.50万
成交额：
1,767.22万
市值：
90.72亿
市盈率：
132.74
高：
13.600
开：
13.550
低：
13.150
收：
13.550
52周最高：
19.780
52周最低：
6.560
股本：
6.74亿
香港流通股本：
6.74亿
量比：
1.05
换手率：
0.20%
股息：
- -
股息率：
- -
每股收益(LYR):
0.101
净资产收益率：
2.85%
总资产收益率：
0.78%
市净率：
4.11
市盈率(LYR):
132.74
市销率:
12.93
数据加载中...
总览
公司
新闻资讯
公告
和誉-B盘中异动 早盘股价大涨5.45%
市场透视
·
01/05
和誉-B：匹米替尼获批上市 正式迈入商业化阶段
天风证券
·
01/05
每日卖空追踪 | 和誉-B 01月02日卖空量成交1.5万股，卖空比例为1.38%
市场透视
·
01/02
和誉-B01月02日获主力加仓63.7万元
市场透视
·
01/02
【券商聚焦】西部证券维持和誉-B“买入”评级 指匹米替尼开启全球商业化
金吾财讯
·
2025/12/31
引领中国创新药全球多中心同步临床开发新实践——访和誉医药董事长徐耀昌
经济参考网
·
2025/12/30
每日卖空追踪 | 和誉-B 12月30日卖空量成交5.5万股，卖空比例为2.48%
市场透视
·
2025/12/30
和誉-B12月30日获主力加仓85.1万元
市场透视
·
2025/12/30
和誉医药匹米替尼国内率先获批 开创全球同步研发新范式
新华财经
·
2025/12/30
每日卖空追踪 | 和誉-B 12月29日卖空量成交5.4万股，卖空比例为3.41%
市场透视
·
2025/12/29
申万宏源：维持和誉-B(02256)“买入”评级 首款自研新药获批上市
智通财经
·
2025/12/29
《大行》中金：和誉-B(02256.HK)匹米替尼获批速度快过预期
阿斯达克财经
·
2025/12/24
中金：维持和誉-B(02256)跑赢行业评级 目标价20港元
智通财经
·
2025/12/24
【湾区早参】香港新年假期预计有约1152万人次进出；广州1—11月经济数据出炉
金吾财讯
·
2025/12/24
和誉-B(02256)：口服小分子KRAS G12D抑制剂ABSK141的IND获NMPA批准
智通财经
·
2025/12/24
和誉-B(02256)：匹米替尼顺利获批，“十亿美元分子”价值加速兑现成配置关键
智通财经
·
2025/12/23
和誉-B的Csf-1R抑制剂Pimicotinib获得中国NMPA批准，填补腱鞘巨细胞瘤的治疗空白
美股速递
·
2025/12/22
国内腱鞘巨细胞瘤首款自研药物获批上市
新华日报财经
·
2025/12/22
罕见病治疗药物贝捷迈在华获批 国内首个获批用于TGCT治疗一类创新药
中国网财经
·
2025/12/22
和誉-B(02256)：和誉医药CSF-1R抑制剂贝捷迈®获中国NMPA批准
智通财经
·
2025/12/22
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02256/news?page=5"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02256","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02256\",,,,,undefined,":{"symbol":"02256","market":"HK","secType":"STK","nameCN":"和誉-B","latestPrice":13.46,"timestamp":1776411159949,"preClose":13.55,"halted":0,"volume":1315000,"delay":0,"changeRate":-0.006642066420664196,"floatShares":674000000,"shares":674000000,"eps":0.1014022771097542,"marketStatus":"交易中","change":-0.09,"latestTime":"04-17 15:33:50","open":13.55,"high":13.6,"low":13.15,"amount":17672168,"amplitude":0.03321,"askPrice":13.56,"askSize":16000,"bidPrice":13.43,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":0.10433512603726319,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1776413400000},"marketStatusCode":2,"adr":0,"listingDate":1634054400000,"exchange":"SEHK","adjPreClose":13.55,"openAndCloseTimeList":[[1776389400000,1776398400000],[1776402000000,1776412800000]],"volumeRatio":1.050268,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02256\",,,,,undefined,":{"symbol":"02256","floatShares":674000000,"roa":"0.78%","roe":"2.85%","lyrEps":0.101402,"volumeRatio":1.050268,"shares":674000000,"dividePrice":0,"high":13.6,"amplitude":0.03321,"preClose":13.55,"low":13.15,"week52Low":6.56,"pbRate":"4.11","psRate":"12.93","week52High":19.78,"institutionHeld":0,"latestPrice":13.46,"committee":-0.6,"eps":0.1014022771097542,"divideRate":0,"volume":1315000,"delay":0,"ttmEps":0.10433512603726319,"open":13.55,"prevYearClose":13.01,"prevWeekClose":13.25,"prevMonthClose":12.09,"prevQuarterClose":12.09,"fiveDayClose":13.25,"twentyDayClose":12.33,"sixtyDayClose":14.73},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02256\",params:#limit:5,,,undefined,":[{"date":"2026-03-02","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772415000000,"name":null,"time":"","dateTimestamp":1772380800000,"actualEps":null},{"date":"2025-08-04","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1754271000000,"name":null,"time":"","dateTimestamp":1754236800000,"actualEps":null},{"date":"2025-03-03","symbol":"02256","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740965400000,"name":null,"time":"盘后","dateTimestamp":1740931200000,"actualEps":null},{"date":"2024-08-12","symbol":"02256","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723426200000,"name":null,"time":"盘后","dateTimestamp":1723392000000,"actualEps":null},{"date":"2024-03-12","symbol":"02256","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710207000000,"name":null,"time":"","dateTimestamp":1710172800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02256\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02256\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1762272000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02256\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02256","date":"2026-04-15","current":129.823015,"percent":0.913357,"low":-234.512257,"twenty":-4.810227,"median":-1.494313,"eighty":56.391193,"high":254.727882,"avg":7.878417,"sd":83.656755,"marketCap":9120020679},"quantilePoints":[{"date":"2021-10-15","current":-9.313928,"twenty":-4.877635,"median":-1.919564,"eighty":-1.91666,"marketCap":8710582740},{"date":"2021-10-22","current":-8.650919,"twenty":-8.878249,"median":-8.660561,"eighty":-1.919672,"marketCap":8148609660},{"date":"2021-10-29","current":-8.806935,"twenty":-8.825514,"median":-8.653413,"eighty":-5.845693,"marketCap":8275053603},{"date":"2021-11-05","current":-9.301473,"twenty":-9.072506,"median":-8.661255,"eighty":-8.486758,"marketCap":8754126241},{"date":"2021-11-12","current":-8.237331,"twenty":-8.927135,"median":-8.653413,"eighty":-8.255925,"marketCap":7784568118},{"date":"2021-11-19","current":-7.891647,"twenty":-8.895236,"median":-8.502762,"eighty":-8.001626,"marketCap":7447330510},{"date":"2021-11-26","current":-7.829582,"twenty":-8.864707,"median":-8.396384,"eighty":-7.827763,"marketCap":7391124242},{"date":"2021-12-03","current":-7.421405,"twenty":-8.825514,"median":-8.237331,"eighty":-7.536645,"marketCap":7018757716},{"date":"2021-12-10","current":-6.897038,"twenty":-8.719527,"median":-8.053855,"eighty":-7.419956,"marketCap":6533978655},{"date":"2021-12-17","current":-6.835017,"twenty":-8.660839,"median":-7.891647,"eighty":-7.035882,"marketCap":6470746603},{"date":"2021-12-24","current":-6.74694,"twenty":-8.657769,"median":-7.827308,"eighty":-6.929689,"marketCap":6393462985},{"date":"2021-12-31","current":-6.732295,"twenty":-8.653912,"median":-7.658199,"eighty":-6.817054,"marketCap":6393462985},{"date":"2022-01-07","current":-6.564869,"twenty":-6.733406,"median":-6.682233,"eighty":-6.545813,"marketCap":6210792614},{"date":"2022-01-14","current":-5.928147,"twenty":-6.714875,"median":-6.541049,"eighty":-6.306527,"marketCap":5620626800},{"date":"2022-01-21","current":-5.914607,"twenty":-6.690644,"median":-6.454435,"eighty":-5.918405,"marketCap":5620626800},{"date":"2022-01-28","current":-5.774086,"twenty":-6.634775,"median":-6.223148,"eighty":-5.77564,"marketCap":5473085346},{"date":"2022-02-04","current":-5.576691,"twenty":-6.603137,"median":-6.042935,"eighty":-5.774086,"marketCap":5283389192},{"date":"2022-02-11","current":-4.350779,"twenty":-6.564869,"median":-5.916505,"eighty":-5.570983,"marketCap":4130278698},{"date":"2022-02-18","current":-4.318127,"twenty":-6.517229,"median":-5.781336,"eighty":-4.350779,"marketCap":4119415434},{"date":"2022-02-25","current":-3.815851,"twenty":-6.456658,"median":-5.774086,"eighty":-4.326746,"marketCap":3649226620},{"date":"2022-03-04","current":-3.520975,"twenty":-6.454435,"median":-5.57398,"eighty":-4.051501,"marketCap":3368516880},{"date":"2022-03-11","current":-3.085511,"twenty":-6.318497,"median":-5.537277,"eighty":-3.823357,"marketCap":2947452270},{"date":"2022-03-18","current":-1.525941,"twenty":-6.288573,"median":-4.578518,"eighty":-3.682078,"marketCap":3396587854},{"date":"2022-03-25","current":-1.443908,"twenty":-6.157723,"median":-4.346691,"eighty":-3.085511,"marketCap":3214126523},{"date":"2022-04-01","current":-1.328833,"twenty":-5.928147,"median":-4.322437,"eighty":-2.968177,"marketCap":2961487757},{"date":"2022-04-08","current":-1.375471,"twenty":-5.921366,"median":-4.242175,"eighty":-1.521815,"marketCap":3066753909},{"date":"2022-04-14","current":-1.437651,"twenty":-5.917771,"median":-4.006843,"eighty":-1.445834,"marketCap":3200091036},{"date":"2022-04-22","current":-1.465035,"twenty":-5.915746,"median":-3.893702,"eighty":-1.44567,"marketCap":3200091036},{"date":"2022-04-29","current":-1.247364,"twenty":-5.863479,"median":-3.81646,"eighty":-1.439188,"marketCap":2680778017},{"date":"2022-05-06","current":-1.254519,"twenty":-5.784606,"median":-3.815709,"eighty":-1.377501,"marketCap":2673760273},{"date":"2022-05-13","current":-1.307549,"twenty":-5.775886,"median":-3.520975,"eighty":-1.375471,"marketCap":2736919965},{"date":"2022-05-20","current":-1.23325,"twenty":-5.775272,"median":-3.089354,"eighty":-1.329109,"marketCap":2617618325},{"date":"2022-05-27","current":-1.250867,"twenty":-5.774086,"median":-3.004697,"eighty":-1.3182,"marketCap":2652707043},{"date":"2022-06-02","current":-1.316602,"twenty":-5.762384,"median":-2.968177,"eighty":-1.30953,"marketCap":2807097400},{"date":"2022-06-10","current":-1.15651,"twenty":-5.613245,"median":-2.229502,"eighty":-1.30593,"marketCap":2449192481},{"date":"2022-06-17","current":-1.078161,"twenty":-5.572353,"median":-1.465035,"eighty":-1.267614,"marketCap":2280766637},{"date":"2022-06-24","current":-1.093711,"twenty":-5.57104,"median":-1.447186,"eighty":-1.255725,"marketCap":2322873098},{"date":"2022-06-30","current":-1.184967,"twenty":-5.550759,"median":-1.445752,"eighty":-1.244028,"marketCap":2512352173},{"date":"2022-07-08","current":-1.296171,"twenty":-5.113983,"median":-1.443908,"eighty":-1.246415,"marketCap":2750955452},{"date":"2022-07-15","current":-1.341671,"twenty":-4.816469,"median":-1.4094,"eighty":-1.249466,"marketCap":2821132887},{"date":"2022-07-22","current":-1.367474,"twenty":-4.53297,"median":-1.376774,"eighty":-1.253058,"marketCap":2877274835},{"date":"2022-07-29","current":-1.365808,"twenty":-4.349713,"median":-1.375774,"eighty":-1.255424,"marketCap":2877274835},{"date":"2022-08-05","current":-1.372635,"twenty":-4.347615,"median":-1.371808,"eighty":-1.256374,"marketCap":2884292578},{"date":"2022-08-12","current":-1.280717,"twenty":-4.343959,"median":-1.369947,"eighty":-1.257543,"marketCap":2694813504},{"date":"2022-08-19","current":-1.206073,"twenty":-4.332903,"median":-1.367474,"eighty":-1.255424,"marketCap":2512352173},{"date":"2022-08-26","current":-1.419225,"twenty":-4.321575,"median":-1.369256,"eighty":-1.256374,"marketCap":2680778017},{"date":"2022-09-02","current":-1.491454,"twenty":-4.281721,"median":-1.37074,"eighty":-1.257543,"marketCap":2807097400},{"date":"2022-09-09","current":-1.459725,"twenty":-4.23912,"median":-1.374053,"eighty":-1.260033,"marketCap":2736919965},{"date":"2022-09-16","current":-1.23156,"twenty":-4.15674,"median":-1.374053,"eighty":-1.25723,"marketCap":2287784381},{"date":"2022-09-23","current":-1.271072,"twenty":-4.015774,"median":-1.37074,"eighty":-1.252549,"marketCap":2315855355},{"date":"2022-09-30","current":-1.195605,"twenty":-3.959398,"median":-1.369256,"eighty":-1.248765,"marketCap":2182518228},{"date":"2022-10-07","current":-1.191829,"twenty":-3.930612,"median":-1.367396,"eighty":-1.240217,"marketCap":2175500485},{"date":"2022-10-14","current":-1.32118,"twenty":-3.830419,"median":-1.367209,"eighty":-1.23903,"marketCap":2386032790},{"date":"2022-10-21","current":-1.142485,"twenty":-3.821978,"median":-1.363715,"eighty":-1.234955,"marketCap":2049181102},{"date":"2022-10-28","current":-1.026865,"twenty":-3.816338,"median":-1.357179,"eighty":-1.231371,"marketCap":1838648797},{"date":"2022-11-04","current":-1.114008,"twenty":-3.815823,"median":-1.342128,"eighty":-1.206878,"marketCap":2014092384},{"date":"2022-11-11","current":-1.342699,"twenty":-3.788983,"median":-1.336938,"eighty":-1.206878,"marketCap":2449192481},{"date":"2022-11-18","current":-1.351175,"twenty":-3.649857,"median":-1.338707,"eighty":-1.21324,"marketCap":2456210225},{"date":"2022-11-25","current":-1.358089,"twenty":-3.463579,"median":-1.335946,"eighty":-1.226609,"marketCap":2449192481},{"date":"2022-12-02","current":-1.419205,"twenty":-3.205834,"median":-1.341074,"eighty":-1.230134,"marketCap":2603582838},{"date":"2022-12-09","current":-1.425095,"twenty":-3.091661,"median":-1.342584,"eighty":-1.231371,"marketCap":2638671556},{"date":"2022-12-16","current":-1.344849,"twenty":-3.079858,"median":-1.344625,"eighty":-1.231842,"marketCap":2484281199},{"date":"2022-12-23","current":-1.177326,"twenty":-3.046735,"median":-1.342584,"eighty":-1.226609,"marketCap":2175500485},{"date":"2022-12-30","current":-1.204469,"twenty":-3.015207,"median":-1.341074,"eighty":-1.207841,"marketCap":2252695663},{"date":"2023-01-06","current":-1.106797,"twenty":-2.987775,"median":-1.336442,"eighty":-1.204712,"marketCap":2091287563},{"date":"2023-01-13","current":-1.089671,"twenty":-2.971503,"median":-1.334558,"eighty":-1.199182,"marketCap":2098305306},{"date":"2023-01-20","current":-1.124834,"twenty":-2.954945,"median":-1.333335,"eighty":-1.195449,"marketCap":2147429511},{"date":"2023-01-27","current":-1.087852,"twenty":-2.946123,"median":-1.332603,"eighty":-1.194704,"marketCap":2077252076},{"date":"2023-02-03","current":-1.188278,"twenty":-2.933064,"median":-1.331842,"eighty":-1.192669,"marketCap":2280766637},{"date":"2023-02-10","current":-1.287421,"twenty":-1.525941,"median":-1.328971,"eighty":-1.193989,"marketCap":2456210225},{"date":"2023-02-17","current":-1.281147,"twenty":-1.50531,"median":-1.328646,"eighty":-1.194704,"marketCap":2421121507},{"date":"2023-02-24","current":-1.172942,"twenty":-1.494313,"median":-1.326882,"eighty":-1.194704,"marketCap":2189535972},{"date":"2023-03-03","current":-1.157957,"twenty":-1.493734,"median":-1.321415,"eighty":-1.191829,"marketCap":2175500485},{"date":"2023-03-10","current":-1.211725,"twenty":-1.190652,"median":-1.159041,"eighty":-1.126108,"marketCap":2259713407},{"date":"2023-03-17","current":-3.757269,"twenty":-5.774798,"median":-1.344849,"eighty":-1.195881,"marketCap":2119358537},{"date":"2023-03-24","current":-3.296419,"twenty":-5.768235,"median":-1.346683,"eighty":-1.196353,"marketCap":1880755258},{"date":"2023-03-31","current":-3.65645,"twenty":-5.686352,"median":-1.351175,"eighty":-1.196881,"marketCap":2070234332},{"date":"2023-04-06","current":-3.79524,"twenty":-5.576691,"median":-1.354699,"eighty":-1.197545,"marketCap":2147429511},{"date":"2023-04-14","current":-3.717153,"twenty":-5.572353,"median":-1.357634,"eighty":-1.198435,"marketCap":2105323050},{"date":"2023-04-21","current":-3.570303,"twenty":-5.57104,"median":-1.361622,"eighty":-1.199356,"marketCap":2021110128},{"date":"2023-04-28","current":-3.399211,"twenty":-5.544018,"median":-1.366786,"eighty":-1.200488,"marketCap":1909928659},{"date":"2023-05-05","current":-1.47972,"twenty":-5.113983,"median":-1.367306,"eighty":-1.200742,"marketCap":1806339308},{"date":"2023-05-12","current":-1.457938,"twenty":-4.816469,"median":-1.368747,"eighty":-1.202979,"marketCap":1767493302},{"date":"2023-05-19","current":-1.467897,"twenty":-4.53297,"median":-1.370434,"eighty":-1.204467,"marketCap":1754544633},{"date":"2023-05-25","current":-1.457646,"twenty":-4.350068,"median":-1.372221,"eighty":-1.204631,"marketCap":1735121629},{"date":"2023-06-02","current":-1.462605,"twenty":-4.348078,"median":-1.376078,"eighty":-1.205206,"marketCap":1735121629},{"date":"2023-06-09","current":-1.502976,"twenty":-4.34487,"median":-1.378591,"eighty":-1.205852,"marketCap":1780441971},{"date":"2023-06-16","current":-1.510209,"twenty":-4.335981,"median":-1.40341,"eighty":-1.206957,"marketCap":1780441971},{"date":"2023-06-23","current":-1.48536,"twenty":-4.325022,"median":-1.411271,"eighty":-1.208646,"marketCap":1741595964},{"date":"2023-06-30","current":-1.493347,"twenty":-4.305992,"median":-1.416252,"eighty":-1.210425,"marketCap":1735121629},{"date":"2023-07-07","current":-1.4851,"twenty":-4.251341,"median":-1.419225,"eighty":-1.212479,"marketCap":1722172961},{"date":"2023-07-14","current":-1.443472,"twenty":-4.191819,"median":-1.424435,"eighty":-1.217475,"marketCap":1697389123},{"date":"2023-07-21","current":-1.455748,"twenty":-4.033638,"median":-1.428761,"eighty":-1.225478,"marketCap":1703867707},{"date":"2023-07-28","current":-1.57367,"twenty":-3.960791,"median":-1.43135,"eighty":-1.226609,"marketCap":1839917980},{"date":"2023-08-04","current":-1.510208,"twenty":-3.950465,"median":-1.43932,"eighty":-1.230134,"marketCap":1768653552},{"date":"2023-08-11","current":-1.490967,"twenty":-3.911595,"median":-1.44369,"eighty":-1.231371,"marketCap":1736260629},{"date":"2023-08-18","current":-3.132942,"twenty":-3.830419,"median":-1.444644,"eighty":-1.231842,"marketCap":1626124694},{"date":"2023-08-25","current":-2.969212,"twenty":-3.821978,"median":-1.445275,"eighty":-1.233024,"marketCap":1541903096},{"date":"2023-09-01","current":-2.956935,"twenty":-3.816338,"median":-1.446182,"eighty":-1.233589,"marketCap":1541903096},{"date":"2023-09-08","current":-3.004733,"twenty":-3.815823,"median":-1.448334,"eighty":-1.234955,"marketCap":1548381681},{"date":"2023-09-15","current":-3.01904,"twenty":-3.811615,"median":-1.451164,"eighty":-1.235394,"marketCap":1567817434},{"date":"2023-09-22","current":-2.85831,"twenty":-3.787646,"median":-1.455328,"eighty":-1.237379,"marketCap":1477858669},{"date":"2023-09-29","current":-3.059687,"twenty":-3.751278,"median":-1.457646,"eighty":-1.23903,"marketCap":1584691826},{"date":"2023-10-06","current":-3.026759,"twenty":-3.727312,"median":-1.458125,"eighty":-1.23906,"marketCap":1566886300},{"date":"2023-10-13","current":-3.077215,"twenty":-3.723642,"median":-1.459629,"eighty":-1.244992,"marketCap":1590627001},{"date":"2023-10-20","current":-3.058964,"twenty":-3.720543,"median":-1.462605,"eighty":-1.24512,"marketCap":1578756651},{"date":"2023-10-27","current":-2.991248,"twenty":-3.717831,"median":-1.465035,"eighty":-1.246735,"marketCap":1543145598},{"date":"2023-11-03","current":-3.545569,"twenty":-3.717153,"median":-1.467897,"eighty":-1.247319,"marketCap":1833969192},{"date":"2023-11-10","current":-4.143101,"twenty":-3.733303,"median":-1.474061,"eighty":-1.248161,"marketCap":2142598312},{"date":"2023-11-17","current":-4.037822,"twenty":-3.815973,"median":-1.480171,"eighty":-1.24945,"marketCap":2106987259},{"date":"2023-11-24","current":-4.106384,"twenty":-3.936201,"median":-1.481481,"eighty":-1.250638,"marketCap":2160403838},{"date":"2023-12-01","current":-4.785978,"twenty":-3.975325,"median":-1.482715,"eighty":-1.251161,"marketCap":2528384711},{"date":"2023-12-08","current":-3.891697,"twenty":-4.03647,"median":-1.4851,"eighty":-1.251909,"marketCap":2047635506},{"date":"2023-12-15","current":-4.22825,"twenty":-4.04732,"median":-1.485381,"eighty":-1.254031,"marketCap":2237561118},{"date":"2023-12-22","current":-3.928054,"twenty":-4.053689,"median":-1.486481,"eighty":-1.255725,"marketCap":2077311383},{"date":"2023-12-29","current":-4.074674,"twenty":-4.058065,"median":-1.490204,"eighty":-1.256258,"marketCap":2166339013},{"date":"2024-01-05","current":-3.788817,"twenty":-4.056443,"median":-1.492272,"eighty":-1.256918,"marketCap":2000154103},{"date":"2024-01-12","current":-3.483407,"twenty":-4.05084,"median":-1.493347,"eighty":-1.258339,"marketCap":1839904367},{"date":"2024-01-19","current":-2.914334,"twenty":-4.047812,"median":-1.494832,"eighty":-1.259474,"marketCap":1537210423},{"date":"2024-01-26","current":-2.880535,"twenty":-4.044627,"median":-1.497595,"eighty":-1.261418,"marketCap":1513469721},{"date":"2024-02-02","current":-2.567515,"twenty":-4.037992,"median":-1.4988,"eighty":-1.262107,"marketCap":1347284811},{"date":"2024-02-09","current":-2.509912,"twenty":-4.037484,"median":-1.499599,"eighty":-1.26303,"marketCap":1323544109},{"date":"2024-02-16","current":-2.700667,"twenty":-4.03647,"median":-1.502976,"eighty":-1.264369,"marketCap":1424442091},{"date":"2024-02-23","current":-2.873353,"twenty":-4.026782,"median":-1.50531,"eighty":-1.265853,"marketCap":1507534546},{"date":"2024-03-01","current":-3.007226,"twenty":-4.016267,"median":-1.510715,"eighty":-1.267104,"marketCap":1578756651},{"date":"2024-03-08","current":-2.994589,"twenty":-4.004209,"median":-1.514033,"eighty":-1.267614,"marketCap":1572821475},{"date":"2024-03-15","current":-3.717992,"twenty":-3.994485,"median":-1.516618,"eighty":-1.270393,"marketCap":1744815141},{"date":"2024-03-22","current":-3.564943,"twenty":-3.976958,"median":-1.519285,"eighty":-1.272911,"marketCap":1671460637},{"date":"2024-03-28","current":-3.64693,"twenty":-3.970449,"median":-1.523269,"eighty":-1.274866,"marketCap":1704431629},{"date":"2024-04-05","current":-3.527526,"twenty":-3.967421,"median":-1.525007,"eighty":-1.27673,"marketCap":1647541141},{"date":"2024-04-12","current":-3.689898,"twenty":-3.961738,"median":-1.534783,"eighty":-1.2803,"marketCap":1724356386},{"date":"2024-04-19","current":-3.642953,"twenty":-3.959005,"median":-1.540073,"eighty":-1.280803,"marketCap":1700964660},{"date":"2024-04-26","current":-4.107449,"twenty":-3.959005,"median":-1.565243,"eighty":-1.281169,"marketCap":1915482404},{"date":"2024-05-03","current":-4.976884,"twenty":-3.973027,"median":-1.58912,"eighty":-1.281256,"marketCap":2319333229},{"date":"2024-05-10","current":-4.784327,"twenty":-4.024444,"median":-1.91607,"eighty":-1.283533,"marketCap":2234890831},{"date":"2024-05-17","current":-5.194111,"twenty":-4.039682,"median":-2.183001,"eighty":-1.285137,"marketCap":2422751220},{"date":"2024-05-24","current":-4.64921,"twenty":-4.058631,"median":-2.509912,"eighty":-1.28634,"marketCap":2163633442},{"date":"2024-05-31","current":-4.402153,"twenty":-4.106597,"median":-2.550052,"eighty":-1.287245,"marketCap":2050744147},{"date":"2024-06-07","current":-4.13551,"twenty":-4.133471,"median":-2.567515,"eighty":-1.289289,"marketCap":1924139578},{"date":"2024-06-14","current":-4.2508,"twenty":-4.138546,"median":-2.642702,"eighty":-1.289956,"marketCap":1975968254},{"date":"2024-06-21","current":-4.357482,"twenty":-4.155859,"median":-2.683175,"eighty":-1.29202,"marketCap":2021318345},{"date":"2024-06-28","current":-4.540926,"twenty":-4.178794,"median":-2.709261,"eighty":-1.293725,"marketCap":2105539943},{"date":"2024-07-05","current":-4.513963,"twenty":-4.22771,"median":-2.729604,"eighty":-1.294301,"marketCap":2092582774},{"date":"2024-07-12","current":-4.397187,"twenty":-4.243592,"median":-2.759528,"eighty":-1.295064,"marketCap":2041442184},{"date":"2024-07-19","current":-4.220132,"twenty":-4.246463,"median":-2.788193,"eighty":-1.295793,"marketCap":1959278876},{"date":"2024-07-26","current":-4.068882,"twenty":-4.243592,"median":-2.838066,"eighty":-1.296674,"marketCap":1896076332},{"date":"2024-08-02","current":-3.881262,"twenty":-4.234933,"median":-2.853417,"eighty":-1.299007,"marketCap":1807592769},{"date":"2024-08-09","current":-4.030819,"twenty":-4.22771,"median":-2.876944,"eighty":-1.303142,"marketCap":1889756077},{"date":"2024-08-16","current":-110.215085,"twenty":-4.243592,"median":-2.92186,"eighty":-1.305862,"marketCap":1940318113},{"date":"2024-08-23","current":-110.378813,"twenty":-4.25597,"median":-2.932478,"eighty":-1.306376,"marketCap":1951413621},{"date":"2024-08-30","current":-111.169888,"twenty":-4.272942,"median":-2.946123,"eighty":-1.307217,"marketCap":1978593894},{"date":"2024-09-06","current":-112.071186,"twenty":-4.323518,"median":-2.954611,"eighty":-1.307853,"marketCap":1995595657},{"date":"2024-09-13","current":-101.344705,"twenty":-4.348078,"median":-2.964171,"eighty":-1.30892,"marketCap":1799870769},{"date":"2024-09-20","current":-109.898813,"twenty":-4.365964,"median":-2.968177,"eighty":-1.311188,"marketCap":1963495385},{"date":"2024-09-27","current":-119.045575,"twenty":-4.40116,"median":-2.97652,"eighty":-1.316813,"marketCap":2139706509},{"date":"2024-10-04","current":-139.784796,"twenty":-4.434604,"median":-2.983036,"eighty":-1.317658,"marketCap":2501057776},{"date":"2024-10-10","current":-121.076225,"twenty":-4.514518,"median":-2.991277,"eighty":-1.318017,"marketCap":2152293018},{"date":"2024-10-18","current":-136.483117,"twenty":-4.546226,"median":-2.994589,"eighty":-1.318181,"marketCap":2413520753},{"date":"2024-10-25","current":-148.160756,"twenty":-4.649306,"median":-3.00209,"eighty":-1.320584,"marketCap":2619858020},{"date":"2024-11-01","current":-152.301356,"twenty":-4.729636,"median":-3.007226,"eighty":-1.321368,"marketCap":2694889753},{"date":"2024-11-08","current":-175.184116,"twenty":-4.749387,"median":-3.020226,"eighty":-1.321799,"marketCap":3076301064},{"date":"2024-11-15","current":-156.067929,"twenty":-4.801593,"median":-3.026759,"eighty":-1.324719,"marketCap":2719900331},{"date":"2024-11-22","current":-150.055075,"twenty":-4.857642,"median":-3.029314,"eighty":-1.327756,"marketCap":2613605375},{"date":"2024-11-29","current":-166.303938,"twenty":-5.049525,"median":-3.046032,"eighty":-1.328549,"marketCap":2894974375},{"date":"2024-12-06","current":-174.977402,"twenty":-5.544018,"median":-3.050955,"eighty":-1.328637,"marketCap":3038785197},{"date":"2024-12-13","current":-157.839535,"twenty":-5.762384,"median":-3.054687,"eighty":-1.328715,"marketCap":2738658264},{"date":"2024-12-20","current":-157.261391,"twenty":-5.81235,"median":-3.05764,"eighty":-1.328813,"marketCap":2713647686},{"date":"2024-12-27","current":-161.735106,"twenty":-5.918405,"median":-3.058964,"eighty":-1.328943,"marketCap":2788679420},{"date":"2025-01-03","current":-161.576912,"twenty":-6.262403,"median":-3.0609,"eighty":-1.329656,"marketCap":2788679420},{"date":"2025-01-10","current":-160.009513,"twenty":-6.505115,"median":-3.073313,"eighty":-1.331919,"marketCap":2751163553},{"date":"2025-01-17","current":-163.8775,"twenty":-6.673144,"median":-3.085511,"eighty":-1.33225,"marketCap":2819942642},{"date":"2025-01-24","current":-170.801291,"twenty":-6.744567,"median":-3.092579,"eighty":-1.33245,"marketCap":2957500820},{"date":"2025-01-28","current":-173.143828,"twenty":-6.751024,"median":-3.096083,"eighty":-1.332653,"marketCap":3013774620},{"date":"2025-02-07","current":-175.935342,"twenty":-6.827912,"median":-3.103292,"eighty":-1.333431,"marketCap":3045037842},{"date":"2025-02-14","current":-180.702049,"twenty":-6.966007,"median":-3.137967,"eighty":-1.333994,"marketCap":3120069575},{"date":"2025-02-21","current":-234.099528,"twenty":-7.122579,"median":-3.157846,"eighty":-1.33438,"marketCap":4064218886},{"date":"2025-02-28","current":-217.890434,"twenty":-7.428225,"median":-3.248798,"eighty":-1.334681,"marketCap":3770344597},{"date":"2025-03-07","current":156.564078,"twenty":-7.428225,"median":-3.233993,"eighty":-1.333431,"marketCap":4752009774},{"date":"2025-03-14","current":163.096911,"twenty":-7.421807,"median":-3.143712,"eighty":-1.330749,"marketCap":4952094396},{"date":"2025-03-21","current":162.954964,"twenty":-7.419231,"median":-3.12686,"eighty":-1.328628,"marketCap":4945841752},{"date":"2025-03-28","current":176.290417,"twenty":-7.24304,"median":-3.099502,"eighty":-1.321703,"marketCap":5339758351},{"date":"2025-04-03","current":161.577767,"twenty":-7.123902,"median":-3.092579,"eighty":-1.318144,"marketCap":4895820596},{"date":"2025-04-11","current":142.214826,"twenty":-7.086528,"median":-3.085511,"eighty":-1.30892,"marketCap":4270556152},{"date":"2025-04-17","current":142.082188,"twenty":-7.03615,"median":-3.077215,"eighty":-1.30617,"marketCap":4276808796},{"date":"2025-04-25","current":157.525338,"twenty":-7.035077,"median":-3.06483,"eighty":-1.297429,"marketCap":4745757129},{"date":"2025-05-02","current":164.646937,"twenty":-6.98082,"median":-3.059687,"eighty":-1.294598,"marketCap":4970852329},{"date":"2025-05-09","current":160.887021,"twenty":-6.966007,"median":-3.058035,"eighty":-1.289956,"marketCap":4891435796},{"date":"2025-05-16","current":166.920406,"twenty":-6.956944,"median":-3.054843,"eighty":-1.284736,"marketCap":5116329396},{"date":"2025-05-23","current":172.811396,"twenty":-6.918805,"median":-3.051744,"eighty":-1.280509,"marketCap":5312740129},{"date":"2025-05-30","current":194.14447,"twenty":-6.859825,"median":-3.047185,"eighty":-1.269715,"marketCap":5994823373},{"date":"2025-06-06","current":193.852557,"twenty":-6.827912,"median":-3.029734,"eighty":-1.263923,"marketCap":6001081017},{"date":"2025-06-13","current":206.909864,"twenty":-6.817054,"median":-3.027014,"eighty":-1.258681,"marketCap":6407827906},{"date":"2025-06-20","current":226.129725,"twenty":-6.80981,"median":-3.021411,"eighty":-1.253542,"marketCap":6989324733},{"date":"2025-06-27","current":219.382855,"twenty":-6.774951,"median":-3.010594,"eighty":-1.249178,"marketCap":6799778035},{"date":"2025-07-04","current":207.131321,"twenty":-6.751721,"median":-3.004715,"eighty":-1.245928,"marketCap":6420343195},{"date":"2025-07-11","current":194.227376,"twenty":-6.748553,"median":-2.997106,"eighty":-1.23779,"marketCap":6014301773},{"date":"2025-07-18","current":239.206864,"twenty":-6.742193,"median":-2.992401,"eighty":-1.233081,"marketCap":7401298850},{"date":"2025-07-25","current":223.606361,"twenty":-6.733962,"median":-2.987644,"eighty":-1.227416,"marketCap":6943764012},{"date":"2025-08-01","current":221.508288,"twenty":-6.720681,"median":-2.97652,"eighty":-1.21075,"marketCap":6836108756},{"date":"2025-08-08","current":50.470458,"twenty":-6.69485,"median":-2.968177,"eighty":-1.205206,"marketCap":8274964605},{"date":"2025-08-15","current":65.75115,"twenty":-6.664055,"median":-2.960553,"eighty":-1.200737,"marketCap":10764181600},{"date":"2025-08-22","current":69.328024,"twenty":-6.623327,"median":-2.952385,"eighty":-1.196881,"marketCap":11314163907},{"date":"2025-08-29","current":70.197956,"twenty":-6.58783,"median":-2.944688,"eighty":-1.195394,"marketCap":11510826312},{"date":"2025-09-05","current":74.741403,"twenty":-6.545813,"median":-2.931892,"eighty":-1.193197,"marketCap":12243700183},{"date":"2025-09-12","current":74.279336,"twenty":-6.493001,"median":-2.918097,"eighty":-1.190811,"marketCap":12189911275},{"date":"2025-09-19","current":71.544121,"twenty":-6.455769,"median":-2.873353,"eighty":-1.179252,"marketCap":11732705557},{"date":"2025-09-26","current":69.674923,"twenty":-6.40006,"median":-2.852194,"eighty":-1.166431,"marketCap":11396524882},{"date":"2025-10-03","current":74.307,"twenty":-6.312512,"median":-2.838066,"eighty":-1.159178,"marketCap":12183187662},{"date":"2025-10-10","current":70.431829,"twenty":-6.288573,"median":-2.801814,"eighty":-1.154706,"marketCap":11530997152},{"date":"2025-10-17","current":63.17088,"twenty":-6.157723,"median":-2.769702,"eighty":-1.141961,"marketCap":10334193949},{"date":"2025-10-24","current":58.25878,"twenty":-5.928147,"median":-2.735891,"eighty":-1.138284,"marketCap":9534083943},{"date":"2025-10-31","current":59.730926,"twenty":-5.921366,"median":-2.711752,"eighty":-1.135193,"marketCap":9789581256},{"date":"2025-11-07","current":58.126276,"twenty":-5.917138,"median":-2.68435,"eighty":-1.120838,"marketCap":9520636716},{"date":"2025-11-14","current":60.172448,"twenty":-5.914987,"median":-2.645577,"eighty":-1.113983,"marketCap":9883711845},{"date":"2025-11-21","current":53.525201,"twenty":-5.81235,"median":-2.567515,"eighty":-1.103539,"marketCap":8787762844},{"date":"2025-11-28","current":58.350437,"twenty":-5.778066,"median":-2.550052,"eighty":-1.098391,"marketCap":9614767305},{"date":"2025-12-05","current":57.842944,"twenty":-5.775395,"median":-2.509912,"eighty":-1.092946,"marketCap":9547531170},{"date":"2025-12-12","current":58.224062,"twenty":-5.774323,"median":-2.183001,"eighty":-1.08917,"marketCap":9628214532},{"date":"2025-12-19","current":54.679817,"twenty":-5.762384,"median":-1.913119,"eighty":-1.074189,"marketCap":9063430998},{"date":"2025-12-24","current":54.10565,"twenty":-5.686352,"median":-1.597844,"eighty":-1.065407,"marketCap":8996194863},{"date":"2026-01-02","current":52.443492,"twenty":-5.575606,"median":-1.569456,"eighty":-1.038831,"marketCap":8754144777},{"date":"2026-01-09","current":57.857956,"twenty":-5.571211,"median":-1.54358,"eighty":49.652014,"marketCap":9682003440},{"date":"2026-01-16","current":58.071036,"twenty":-5.564242,"median":-1.534833,"eighty":52.436859,"marketCap":9749239575},{"date":"2026-01-23","current":55.601293,"twenty":-5.468644,"median":-1.525941,"eighty":53.637621,"marketCap":9325651924},{"date":"2026-01-30","current":49.88128,"twenty":-5.183001,"median":-1.52299,"eighty":53.637621,"marketCap":8404516875},{"date":"2026-02-06","current":50.312337,"twenty":-5.136266,"median":-1.517963,"eighty":53.524919,"marketCap":8498647464},{"date":"2026-02-13","current":50.856111,"twenty":-5.107703,"median":-1.515573,"eighty":53.489701,"marketCap":8639843347},{"date":"2026-02-20","current":52.277019,"twenty":-5.068918,"median":-1.514739,"eighty":53.421518,"marketCap":8868446206},{"date":"2026-02-27","current":49.828129,"twenty":-4.998183,"median":-1.511222,"eighty":53.106998,"marketCap":8545712758},{"date":"2026-03-06","current":127.465929,"twenty":-4.960983,"median":-1.507759,"eighty":53.421518,"marketCap":7987652838},{"date":"2026-03-13","current":129.444808,"twenty":-4.904282,"median":-1.502976,"eighty":53.76928,"marketCap":8149019562},{"date":"2026-03-20","current":130.79449,"twenty":-4.861619,"median":-1.499372,"eighty":54.77035,"marketCap":8202808470},{"date":"2026-03-27","current":133.815153,"twenty":-4.840538,"median":-1.498681,"eighty":55.13256,"marketCap":8370898807},{"date":"2026-04-02","current":141.83955,"twenty":-4.825545,"median":-1.497595,"eighty":55.638035,"marketCap":8915511501},{"date":"2026-04-10","current":140.898828,"twenty":-4.816183,"median":-1.495808,"eighty":55.72266,"marketCap":8924687887},{"date":"2026-04-15","current":143.669998,"twenty":-4.810227,"median":-1.494313,"eighty":56.391193,"marketCap":9120020679}],"updateTime":1776376287819},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02256\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2601884774","title":"和誉-B盘中异动 早盘股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601884774","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601884774?lang=zh_cn&edition=fundamental","pubTime":"2026-01-05 10:22","pubTimestamp":1767579750,"startTime":"0","endTime":"0","summary":"2026年01月05日早盘10时22分，和誉-B股票出现异动，股价急速上涨5.45%。截至发稿，该股报13.730港元/股，成交量52.3万股，换手率0.08%，振幅8.60%。和誉-B股票所在的生物技术行业中，整体涨幅为3.25%。该公司拥有两款核心候选产品ABSK011和 ABSK091,以及12款其他在研产品。ABSK091 是一种分子靶向候选产品,也是 FGFR亚型 1、2和3的强效和选择性抑制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105102230a49cdde0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105102230a49cdde0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2476274720.SGD","LU2476274308.USD","LU2488822045.USD","BK1161","IE00B5MMRT66.SGD","02256","LU2778985437.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601884091","title":"和誉-B：匹米替尼获批上市 正式迈入商业化阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2601884091","media":"天风证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601884091?lang=zh_cn&edition=fundamental","pubTime":"2026-01-05 00:00","pubTimestamp":1767542400,"startTime":"0","endTime":"0","summary":"事件CSF-1R 高选择性小分子匹米替尼获批上市，用于治疗手术切除可能会导致功能受限或出现较严重并发症的症状性成人腱鞘巨细胞瘤患者。首个自研创新药产品匹米替尼获批上市，具备BIC 潜力匹米替尼是公司首个获批上市的自研创新药产品，疗效和安全性良好。对照组患者改用匹米替尼后，同样获得临床获益，中位随访时间8.5 个月时，ORR 达到64.5%，COAs 也有所改善。公司与默克就匹米替尼在2023 年订立独家许可协议，默克获得匹米替尼中国地区的商业化权益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105143638a49db01e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105143638a49db01e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B543WZ88.USD","LU2778985437.USD","LU2476274308.USD","LU2488822045.USD","BK1161","LU2476274720.SGD","IE00B5MMRT66.SGD","02256","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600062285","title":"每日卖空追踪 | 和誉-B 01月02日卖空量成交1.5万股，卖空比例为1.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600062285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600062285?lang=zh_cn&edition=fundamental","pubTime":"2026-01-02 16:30","pubTimestamp":1767342629,"startTime":"0","endTime":"0","summary":"和誉-B北京时间01月02日，涨0.08%，卖空量成交1.5万股，较上一交易日减少85.58%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163316a6eb2a30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163316a6eb2a30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B543WZ88.USD","02256","BK1161","LU2476274308.USD","LU2488822045.USD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU2476274720.SGD","LU2778985437.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600062405","title":"和誉-B01月02日获主力加仓63.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600062405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600062405?lang=zh_cn&edition=fundamental","pubTime":"2026-01-02 16:15","pubTimestamp":1767341757,"startTime":"0","endTime":"0","summary":"01月02日, 和誉-B股价涨0.08%，报收13.02元，成交金额1412.5万元，换手率0.16%，振幅2.54%，量比0.60。和誉-B今日主力资金净流入63.7万元，连续4日净流入，上一交易日主力净流入85.1万元。该股近5个交易日下跌3.13%，主力资金累计净流入191.6万元；近20日主力资金累计净流入726.6万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102162007a4942359&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102162007a4942359&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2476274720.SGD","LU2476274308.USD","LU2488822045.USD","BK1161","IE00B5MMRT66.SGD","02256","LU2778985437.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600818700","title":"【券商聚焦】西部证券维持和誉-B“买入”评级 指匹米替尼开启全球商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2600818700","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600818700?lang=zh_cn&edition=fundamental","pubTime":"2025-12-31 10:48","pubTimestamp":1767149329,"startTime":"0","endTime":"0","summary":"）获NMPA批准上市，成为中国首个自主研发的腱鞘巨细胞瘤系统性治疗药物，其全球商业化权益由默克负责。当前股价12.9港元，维持\"买入\"评级。研发管线方面，除已获批的匹米替尼外，KRAS G12D抑制剂ABSK141在12月初获FDA IND批准，PD-L1抑制剂ABSK043联合疗法II期临床显示可控安全性。主要风险包括商业化进度不及预期、临床开发延迟及海外上市受阻。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231114718a48ccf37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231114718a48ccf37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595796611","title":"引领中国创新药全球多中心同步临床开发新实践——访和誉医药董事长徐耀昌","url":"https://stock-news.laohu8.com/highlight/detail?id=2595796611","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595796611?lang=zh_cn&edition=fundamental","pubTime":"2025-12-30 18:22","pubTimestamp":1767090149,"startTime":"0","endTime":"0","summary":"近日，和誉医药（02256.HK）自主研发的一类新药贝捷迈（盐酸匹米替尼胶囊）获国家药品监督管理局批准上市，填补了国内腱鞘巨细胞瘤（TGCT）系统疗法的临床空白。《经济参考报》记者走进和誉医药，探寻在这场里程碑式的突破背后，和誉医药董事长兼CEO徐耀昌博士带领团队，用科学坚守与务实创新，书写了中国医药产业高质量发展的“生动答卷”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512303605811750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BPRC5H50.USD","BK1515","02256","BK1574","IE00B5MMRT66.SGD","LU2488822045.USD","LU2476274720.SGD","159992","LU2476274308.USD","BK1161","IE00B543WZ88.USD","159938","09939","06978","LU2778985437.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595725535","title":"每日卖空追踪 | 和誉-B 12月30日卖空量成交5.5万股，卖空比例为2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595725535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595725535?lang=zh_cn&edition=fundamental","pubTime":"2025-12-30 16:30","pubTimestamp":1767083428,"startTime":"0","endTime":"0","summary":"和誉-B北京时间12月30日，涨1.63%，卖空量成交5.5万股，较上一交易日减少63.09%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163414a4897ec8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163414a4897ec8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2476274720.SGD","02256","LU2488822045.USD","LU2476274308.USD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","BK1161","LU2778985437.USD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595255367","title":"和誉-B12月30日获主力加仓85.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595255367","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595255367?lang=zh_cn&edition=fundamental","pubTime":"2025-12-30 16:15","pubTimestamp":1767082518,"startTime":"0","endTime":"0","summary":"12月30日, 和誉-B股价涨1.63%，报收13.11元，成交金额2889.3万元，换手率0.33%，振幅3.26%，量比1.46。和誉-B今日主力资金净流入85.1万元，连续3日净流入，上一交易日主力净流入32.6万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为62.50%，平均涨幅为4.35%。该股近5个交易日下跌2.74%，主力资金累计净流入150.1万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入662.9万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230161602a48969e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230161602a48969e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2476274720.SGD","02256","LU2488822045.USD","LU2476274308.USD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","BK1161","LU2778985437.USD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595763479","title":"和誉医药匹米替尼国内率先获批 开创全球同步研发新范式","url":"https://stock-news.laohu8.com/highlight/detail?id=2595763479","media":"新华财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595763479?lang=zh_cn&edition=fundamental","pubTime":"2025-12-30 11:35","pubTimestamp":1767065706,"startTime":"0","endTime":"0","summary":"新华财经上海12月30日电（记者胡洁菲、高少华）上海和誉生物医药科技有限公司自主研发的CSF-1R高选择性小分子抑制剂匹米替尼日前获中国国家药品监督管理局（NMPA）批准上市，适用于手术切除可能导致功能受限或严重并发症的症状性腱鞘巨细胞瘤（TGCT）成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512303605500421.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2476274720.SGD","159938","IE00BPRC5H50.USD","02256","IE00B543WZ88.USD","LU2778985437.USD","LU2488822045.USD","BK1574","BK1161","09939","BK1515","LU2476274308.USD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595619647","title":"每日卖空追踪 | 和誉-B 12月29日卖空量成交5.4万股，卖空比例为3.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595619647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595619647?lang=zh_cn&edition=fundamental","pubTime":"2025-12-29 16:30","pubTimestamp":1766997027,"startTime":"0","endTime":"0","summary":"和誉-B北京时间12月29日，跌3.59%，卖空量成交5.4万股，较上一交易日减少32.5%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163356a4854a17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163356a4854a17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU2476274308.USD","IE00BPRC5H50.USD","02256","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU2476274720.SGD","LU2778985437.USD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595684204","title":"申万宏源：维持和誉-B(02256)“买入”评级 首款自研新药获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2595684204","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595684204?lang=zh_cn&edition=fundamental","pubTime":"2025-12-29 13:58","pubTimestamp":1766987921,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，申万宏源发布研报称，12月22日，和誉-B公告，CSF-1R抑制剂匹米替尼获中国药监局批准上市，用于手术切除可能会导致功能受限或出现较严重并发症的症状性腱鞘巨细胞瘤成年患者。首款自研新药获批上市，开启商业化新征程，同时在研管线稳步推进，实现“自我造血”的良性循环，维持“买入”评级。凭借匹米替尼在产品力上差异化的优势，以及默克强大的全球商业化能力，该行看好该产品上市后的放量情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386425.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000166","02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593984440","title":"《大行》中金：和誉-B(02256.HK)匹米替尼获批速度快过预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2593984440","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593984440?lang=zh_cn&edition=fundamental","pubTime":"2025-12-24 09:57","pubTimestamp":1766541420,"startTime":"0","endTime":"0","summary":"中金发表报告指，和誉-B于前日公告CSF-1R抑制剂匹米替尼(贝捷迈)在中国获批上市，用于不适合手术的腱鞘巨细胞瘤的治疗，这是公司第一个获批上市的自研创新药物。该行指，匹米替尼获批速度超该行预期，临床证据确凿。2025年6月，公司公告匹米替尼在中国的上市申请获得受理，到如今获批仅用了6个多月。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221020124424218_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221020124424218_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1492256/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1492256/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2476274720.SGD","02256","LU2488822045.USD","LU2476274308.USD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","BK1161","LU2778985437.USD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593447842","title":"中金：维持和誉-B(02256)跑赢行业评级 目标价20港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593447842","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593447842?lang=zh_cn&edition=fundamental","pubTime":"2025-12-24 09:12","pubTimestamp":1766538771,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，维持和誉-B2025年/2026年归母净利润预测0.48亿元/3.20亿元不变。根据DCF模型，该行维持跑赢行业评级和目标价20港币不变，较当前股价有48.8%的上行空间。匹米替尼获批速度超该行预期，临床证据确凿2025年6月，公司公告匹米替尼在中国的上市申请获得受理，到如今获批仅用了6个多月。该行期待匹米替尼商业化为公司带来新的动能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385267.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593444138","title":"【湾区早参】香港新年假期预计有约1152万人次进出；广州1—11月经济数据出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2593444138","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593444138?lang=zh_cn&edition=fundamental","pubTime":"2025-12-24 08:33","pubTimestamp":1766536413,"startTime":"0","endTime":"0","summary":"经香港入境处与深圳出入境边防检查总站等内地部门协商后，预计有约965万人次会经各陆路边境管制站进出香港。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1972128","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0210526637.USD","LU1023057109.AUD","LU2097828557.USD","LU0456854461.SGD","02256","LU0307460666.USD","BK1610","LU1719994722.HKD","LU0244354667.USD","LU0572944931.SGD","LU0266512127.USD","LU0348767384.USD","81024","LU2097828805.USD","LU0359201612.USD","LU1770034418.SGD","BK1583","LU0211977185.USD","BK1608","BK1095","LU1720050803.USD","BK4213","LU0140636845.USD","LU2097828474.EUR","LU2097828631.EUR","BK1191","LU2097828714.EUR","LU0348766576.USD","LU0051755006.USD","02652","LU0463099449.HKD","LU0588546209.SGD","LU1794554557.SGD","LU0359202008.SGD","LU0593848301.USD","LU0326950275.SGD","LU0456827905.SGD","LU1303224171.USD","BK1591","LU1251922891.USD","LU0327786744.USD","LU0359201885.HKD","BK1590","LU1188198961.HKD","BK1615","BK1575","KSTmain","BK1109","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593418484","title":"和誉-B(02256)：口服小分子KRAS G12D抑制剂ABSK141的IND获NMPA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2593418484","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593418484?lang=zh_cn&edition=fundamental","pubTime":"2025-12-24 08:02","pubTimestamp":1766534531,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，公司的附属公司上海和誉生物医药科技有限公司(和誉医药)宣布，其口服、高活性、高选择性小分子KRAS G12D抑制剂ABSK141用于治疗携带KRAS G12D突变的晚期实体瘤患者的新药临床试验(IND)申请已获中国国家药品监督管理局(NMPA)批准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385238.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B5MMRT66.SGD","LU2476274720.SGD","LU2476274308.USD","IE00BPRC5H50.USD","02256","IND","LU2488822045.USD","LU2778985437.USD","IE00B543WZ88.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593454416","title":"和誉-B(02256)：匹米替尼顺利获批，“十亿美元分子”价值加速兑现成配置关键","url":"https://stock-news.laohu8.com/highlight/detail?id=2593454416","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593454416?lang=zh_cn&edition=fundamental","pubTime":"2025-12-23 09:04","pubTimestamp":1766451870,"startTime":"0","endTime":"0","summary":"今年4月1日，默克再次宣布行使全球商业化选择权，支付8500万美元锁定匹米替尼全球权益。如今匹米替尼在中国获批上市，意味着这款“十亿美元分子”已踏出全球商业化的关键一步，也标志着和誉迎来从开创性创新研究迈向首个产品商业化的关键里程碑。招商证券国际发表报告称，和誉开发的匹米替尼是全球疗效最优CSF-1R小分子。目前，核心品种匹米替尼顺利获批上市，标志着和誉已迈入商业化造血新阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和誉-B(02256)：匹米替尼顺利获批，“十亿美元分子”价值加速兑现成配置关键","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B5MMRT66.SGD","LU2476274720.SGD","LU2488822045.USD","IE00B543WZ88.USD","BK1161","LU2778985437.USD","IE00BPRC5H50.USD","LU2476274308.USD","02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184306238","title":"和誉-B的Csf-1R抑制剂Pimicotinib获得中国NMPA批准，填补腱鞘巨细胞瘤的治疗空白","url":"https://stock-news.laohu8.com/highlight/detail?id=1184306238","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184306238?lang=zh_cn&edition=fundamental","pubTime":"2025-12-22 19:31","pubTimestamp":1766403072,"startTime":"0","endTime":"0","summary":"和誉-B的Csf-1R抑制剂Pimicotinib获得中国NMPA批准，填补腱鞘巨细胞瘤的治疗空白","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","IE00BPRC5H50.USD","LU2476274720.SGD","IE00B543WZ88.USD","BK1161","IE00B5MMRT66.SGD","LU2476274308.USD","LU2778985437.USD","02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593370704","title":"国内腱鞘巨细胞瘤首款自研药物获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2593370704","media":"新华日报财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593370704?lang=zh_cn&edition=fundamental","pubTime":"2025-12-22 18:17","pubTimestamp":1766398620,"startTime":"0","endTime":"0","summary":"新华日报财经讯 12月22日，国家药监局 官网显示，国内腱鞘巨细胞瘤首款自研药物——盐酸匹米替尼胶囊，已通过 CDE 优先审评程序获批上市。公开信息显示，盐酸匹米替尼胶囊是由和誉医药独立研发的一种新型、口服、高选择性且高效的小分子 CSF-1R 抑制剂，用于治疗手术切除可能会导致功能受限或出现较严重并发症的症状性腱鞘巨细胞瘤成年患者。作为港股创新药代表之一，此番首款自研药物获批上市，为创新药企实现商业化做了一次很好的示范。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222181812a6c103cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222181812a6c103cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","IE00B543WZ88.USD","09939","LU2488822045.USD","LU2476274720.SGD","BK1161","BK1515","LU2778985437.USD","LU2476274308.USD","02256","IE00B5MMRT66.SGD","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593043083","title":"罕见病治疗药物贝捷迈在华获批 国内首个获批用于TGCT治疗一类创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2593043083","media":"中国网财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593043083?lang=zh_cn&edition=fundamental","pubTime":"2025-12-22 17:28","pubTimestamp":1766395680,"startTime":"0","endTime":"0","summary":"贝捷迈是一款由和誉医药研发的集落刺激因子-1受体抑制剂，也是国内首个获批用于TGCT治疗的一类创新药。“随着贝捷迈在全球的首个注册获批，我们正持续践行改善罕见肿瘤患者生活的承诺。”蔻德罕见病中心创始人、主任，瑞鸥公益基金会创始人、秘书长黄如方表示，随着贝捷迈在中国获批，这一类系统性治疗方案能够有效控制肿瘤进展、缓解症状，也让患者看到了希望。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222173226a469d45d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222173226a469d45d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","02256","IE00BPRC5H50.USD","LU2778985437.USD","BK1574","06978","LU2476274308.USD","LU2476274720.SGD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593610044","title":"和誉-B(02256)：和誉医药CSF-1R抑制剂贝捷迈®获中国NMPA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2593610044","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593610044?lang=zh_cn&edition=fundamental","pubTime":"2025-12-22 16:32","pubTimestamp":1766392338,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，2025年12月22日，公司的附属公司上海和誉生物医药科技有限公司(“和誉医药”)宣布，中国国家药品监督管理局(“NMPA”)批准贝捷迈®(盐酸匹米替尼胶囊)，适用于手术切除可能会导致功能受限或出现较严重并发症的症状性腱鞘巨细胞瘤(“TGCT”)成年患者。获批后，默克将尽快推动该产品惠及中国TGCT患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384383.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2476274308.USD","09939","BK1574","IE00B543WZ88.USD","IE00B5MMRT66.SGD","CSF","BK1515","IE00BPRC5H50.USD","BK1161","159938","LU2778985437.USD","LU2476274720.SGD","LU2488822045.USD","02256"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":5,"totalSize":167,"code":"91000000","status":"200"}]}}